Advertisement

Here's How Low Analysts Think Aurora Cannabis Can Go

Here's How Low Analysts Think Aurora Cannabis Can Go

Its share price has fallen by 26% over the past year -- undoubtedly frustrating its shareholders -- while the sector benchmark Horizons Marijuana Life Sciences ETF is up by more than 46% over the same period. Analysts on Wall Street are expecting the pot stock to continue to fall after another uninspiring quarter. Since May, when Aurora released its earnings report for the first three months of 2021 (its fiscal third quarter), many analysts have been downgrading the stock and cutting their price targets.